Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
FTSE All-Share News
-
FTSE All-Share
Information -
FTSE All-Share
Constituents -
FTSE All-Share
News 5 -
FTSE All-Share
Charts -
FTSE All-Share
RNS -
FTSE All-Share
Chat -
FTSE All-Share
Risers -
FTSE All-Share
Fallers
FTSE All-Share
FTSE All-Share (ASX) Index Information
Last checked at -
Last checked at 
LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
BT
Oxford Instruments profit up but sales drop after disrupted first half
(Alliance News) - Oxford Instruments PLC on Tuesday said it remains confident in its mid-term goals as it reported mixed annual results.
Oxford Instruments
Deutsche Bank raises target price on AJ Bell
(Sharecast News) - Analysts at Deutsche Bank lifted their target price for AJ Bell from 600p to 675p on Tuesday as they updated the stock's valuation ...
AJ Bell
UK accounting watchdog to probe PwC's fiscal 2024 audit of WH Smith
* FRC to probe PwC's audit of WH Smith accounts for fiscal 2024
Wh Smith
BASF-nominated Harbour Energy director exits as German firm cuts stake
(Sharecast News) - BASF's representation on Harbour Energy's board has been reduced with removal of one of two of its nominated directors, as the Germ...
Harbour Energy
LONDON MARKET OPEN: FTSE 100 down as GSK buys US drugmaker Nuvalent
(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 fell after GSK agreed to buy US-based cancer drug developer Nuvalent...
Glaxosmithkline
MJ Gleeson share fall as warns delays to land sales will hurt profit
(Alliance News) - MJ Gleeson PLC on Tuesday said that three land sales, representing more than half of its expected plot sales in the current financia...
MJGleeson
UPDATE: GSK buys cancer drug developer Nuvalent for USD10.6 billion
(Alliance News) - GSK PLC on Tuesday said it has agreed to US-based cancer drug developer Nuvalent Inc for USD10.6 billion.
Oxford Instruments shares fall despite results ahead of expectations
(Sharecast News) - Oxford Instruments shares fell more than 6% on Tuesday morning despite the company reporting full-year results slightly ahead of ex...
FRC to probe PwC's 2024 audit of WHSmith
(Sharecast News) - The Financial Reporting Council opened an investigation into PwC's audit of WH Smith's accounts for the year ended 31 August 2024 o...
Bellway sticks with annual outlook but demand cools in April and May
(Alliance News) - Bellway PLC on Tuesday backed full-year profit guidance but noted the outlook beyond the current financial year remains uncertain, w...
Bellway
IN BRIEF: Relx launches GBP200 million share buyback programme
Relx PLC - London-based provider of business, scientific and legal information - Commences a new share buyback scheme worth GBP200 million, and runs u...
Relx
Keller secures $207m variation to I-40 contract
(Sharecast News) - Geotechnical contractor Keller said on Tuesday that it has been awarded a contract variation order in relation to the reconstructio...
Keller
AstraZeneca progresses elecoglipron after positive phase IIb results
(Alliance News) - AstraZeneca PLC on Monday announced positive results from the Vista and Solstice phase IIb trials of elecoglipron, an oral small mol...
Astrazeneca
LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...
WPP
Follow the stocks
